Company Number: 14245274

Analysis Date: 2025-07-29 18:29 UTC

Financial Health Assessment for PHASOR ESSEX LIMITED (as of 30 April 2024)

---

1. Financial Health Score: D

Explanation:
PHASOR ESSEX LIMITED shows significant financial stress with net liabilities of £212,012 as of the year-end, compared to net assets of £38,333 the previous year. The company’s working capital position has deteriorated sharply from a positive £30,921 in 2023 to a negative £243,863 in 2024, signalling liquidity challenges. These "symptoms" indicate financial distress that needs urgent attention to prevent worsening conditions.

---

2. Key Vital Signs (Core Financial Metrics)

Metric	2024 Value (£)	2023 Value (£)	Interpretation
Net Assets (Equity)	-212,012	38,333	Negative net assets indicate insolvency risk
Working Capital (Net Current Assets)	-243,863	30,921	Negative working capital shows liquidity strain
Cash and Cash Equivalents	7,643	12,100	Low cash reserves constrain ability to meet obligations
Bank Overdraft	13,032	0	Introduction of overdraft indicates cash flow pressure
Trade Debtors	363,284	217,497	Increase in receivables may strain cash flow
Trade Creditors	347,638	139,531	Sharp increase in payables may reflect payment delays or extended credit terms
Total Liabilities (Current + Non-current)	799,394	438,384	Liabilities almost doubled, worsening financial leverage
Tangible Fixed Assets (Net Book Value)	33,849	18,961	Asset base growing, but insufficient to cover liabilities
Profit & Loss Reserve	-212,112	38,233	Accumulated losses eroding shareholder equity
Number of Employees	4	3	Small workforce, typical for micro/small company

---

3. Diagnosis: What the Financial Data Reveals

• Liquidity Crisis (Healthy Cash Flow Impaired):
  The company’s current assets (£553,532) are insufficient to cover current liabilities (£797,395), leading to a negative working capital of £243,863. This is a critical "symptom" of liquidity distress. The emergence of a bank overdraft (£13,032) further confirms cash flow pressures.

• Solvency Risk (Negative Net Assets):
  The company has slipped from positive net assets (£38,333) to negative net assets (-£212,012) within one year. This suggests accumulated losses have eroded equity, pushing the company into a technically insolvent state.

• Increased Financial Leverage:
  The doubling of creditors and liabilities (both current and long-term) indicates reliance on external funds and possibly suppliers’ credit to finance operations, which is risky if sales or collections slow.

• Asset Position:
  Tangible fixed assets have increased, suggesting investment in property or equipment, but these assets are illiquid and cannot quickly remedy the cash shortfall.

• Receivables and Payables Management:
  Trade debtors increased substantially (+67%) without a corresponding increase in cash, implying longer collection periods or sales on credit, putting strain on liquidity. Trade creditors also increased sharply, potentially reflecting delayed payments to suppliers or stretched terms.

• Going Concern Considerations:
  The directors’ note confirms that the company is reliant on continued financial support from its beneficial owner to meet obligations, which is a crucial lifeline but also a "red flag" about self-sustainability.

• Size and Scale:
  The company is a young private limited company (incorporated July 2022) operating in wholesale electronic and telecom equipment, with a small team of 4 employees. Its total exemption full accounts filing correspond with micro/small company status.

---

4. Recommendations: Specific Actions to Improve Financial Wellness

1. Improve Liquidity Management:

   • Accelerate collection of trade debtors, possibly by tightening credit terms or offering early payment discounts.
   • Negotiate with suppliers to extend payment terms or secure more favourable credit arrangements.
   • Monitor cash flow daily to anticipate shortfalls and manage cash buffers carefully.

2. Cost Control and Operational Efficiency:

   • Review operating expenses and overheads to identify possible reductions without impairing core business.
   • Assess the necessity of recent fixed asset acquisitions to ensure they contribute positively to cash flow or revenue.

3. Equity Injection or Debt Restructuring:

   • Consider capital infusion from shareholders or beneficial owners to restore positive net assets and reduce reliance on overdrafts.
   • Explore refinancing options to convert short-term liabilities into manageable longer-term debts.

4. Financial Reporting and Monitoring:

   • Implement regular financial health checks and detailed management accounts for timely insight into financial symptoms.
   • Engage with a financial advisor or accountant to develop a robust turnaround plan.

5. Strategic Review:

   • Evaluate the business model and sales strategies to improve margins and revenue stability.
   • Explore diversification or focus on higher-margin products/services if feasible.

---

Medical Analogy Summary

PHASOR ESSEX LIMITED exhibits symptoms of financial distress akin to a patient with critical vital signs: negative equity (akin to vital organ failure), severe working capital deficiency (indicating poor circulation of funds), and mounting liabilities (like rising toxins). Without urgent intervention — improving cash flow, reducing burdens, and replenishing capital — the prognosis is guarded. The company currently depends on its "family" (beneficial owner) for life support, but must aim for financial independence to ensure long-term survival.

---